Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Soleno Therapeutics Inc increased its cash reserves by 1,062.04%, or 155.08m. Cash Flow from Financing totalled 180.02m or -- of revenues. In addition the company used 24.94m for operations while cash from investing was breakeven.
Cash flow per share | -3.41 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 6.45 |
---|---|
Tangible book value per share | 6.27 |
More ▼
Balance sheet in USDView more
Current ratio | 17.26 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼